Overview
The HiLyte™ Fluor 555 C2 maleimide is a premium thiol-reactive fluorescent labeling dye designed for generating protein conjugates that are slightly red-shifted compared to Cy3 dyes. This specific shift results in an optimal match for filters tailored for Cy3, giving you flexibility during your experiments. Our HiLyte™ Fluor 555 is not only more photostable than Cy3, but it also offers researchers extended time for image capture, making it an ideal choice for various applications in labeling and detection. With its superior performance in fluorescence polarization-based assays, you’ll find that this product stands out in your research endeavors.
Key Features
- Thiol-reactive labeling dye, perfect for generating protein conjugates.
- Red-shifted emission enhances compatibility with Cy3 filters.
- Improved photostability over traditional Cy3 dyes.
- Outstanding performance in fluorescence polarization assays.
- Easy integration into existing labeling workflows.
Specifications
| Property | Details |
|---|---|
| Product Name | HiLyte™ Fluor 555 C2 maleimide |
| Category | Orange (565-620 nm) |
| Quantity | 1 mg |
FAQ
How does HiLyte™ Fluor 555 compare to Cy3?
HiLyte™ Fluor 555 offers a slightly red-shifted emission spectrum that is better suited for Cy3 filters, alongside enhanced photostability, providing more reliable results during microscopy.
Can I use HiLyte™ Fluor 555 for protein labeling?
Yes, this dye is specifically designed for thiol-reactive labeling of proteins, facilitating the creation of stable protein conjugates.
What applications can benefit from using HiLyte™ Fluor 555?
This dye is ideal for fluorescence microscopy, imaging applications, and fluorescence polarization assays, among others.
Explore our full range of fluorescent labeling options to find the best fit for your research, including alternatives like CyLyte Fluor 3, acid and CyLyte Fluor 3, NHS ester. Don’t miss out on our 5(6)-TAMRA options for diverse labeling needs.
Browse more in Orange (565-620 nm).




Reviews
There are no reviews yet.